找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metallic Nanostructures; From Controlled Synt Yujie Xiong,Xianmao Lu Book 2015 Springer International Publishing Switzerland 2015 Bimetalli

[復制鏈接]
樓主: Dopamine
21#
發(fā)表于 2025-3-25 05:54:30 | 只看該作者
22#
發(fā)表于 2025-3-25 10:41:25 | 只看該作者
Zhenmeng Pengpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
23#
發(fā)表于 2025-3-25 12:44:48 | 只看該作者
W. David Wei,Brendan C. Sweeny,Jingjing Qiu,Joseph S. DuChenepeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
24#
發(fā)表于 2025-3-25 16:23:36 | 只看該作者
Shan Zhou,Yujie Xiongpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
25#
發(fā)表于 2025-3-25 21:59:34 | 只看該作者
26#
發(fā)表于 2025-3-26 03:46:38 | 只看該作者
Ran Long,Yujie Xionge. Relevant chemical modifications also include conjugated targeting ligands to assist ON delivery to specific cell types. Chemical modifications are most beneficial for therapeutically relevant ONs, as they serve to enhance target binding, increase drug longevity, facilitate cell-specific targeting
27#
發(fā)表于 2025-3-26 05:20:44 | 只看該作者
28#
發(fā)表于 2025-3-26 12:29:36 | 只看該作者
Yanglong Hou,Jing Yu,Wenlong Yangintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
29#
發(fā)表于 2025-3-26 14:49:38 | 只看該作者
Zhenmeng Pengintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
30#
發(fā)表于 2025-3-26 17:53:41 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-25 10:27
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
贞丰县| 都江堰市| 筠连县| 中江县| 灵宝市| 凤庆县| 双城市| 徐州市| 郯城县| 渝北区| 同仁县| 渝中区| 曲沃县| 栖霞市| 安多县| 越西县| 中宁县| 平利县| 礼泉县| 郴州市| 霍邱县| 科技| 年辖:市辖区| 文成县| 汾阳市| 平阴县| 马边| 吉水县| 洛南县| 阳曲县| 贵阳市| 额敏县| 无棣县| 金昌市| 油尖旺区| 丰顺县| 武安市| 济阳县| 泸州市| 东城区| 林甸县|